Skip to main content

Advertisement

Altered phosphorylation of Syp may be responsible for abnormal insulin-like growth factor-1 signaling in human osteoarthritic osteoblasts

Article metrics

  • 1439 Accesses

Introduction

The subchondral bone plays a prominent role in the pathophysiology of osteoarthritis (OA), possibly related to abnormal osteoblast metabolism. In particular, abnormal responses to insulin-like growth factor-1 (IGF-1) were noted in OA osteoblasts.

Objectives

To investigate whether IGF-1 signaling is abnormal in OA osteoblasts compared with normal osteoblasts.

Methods

We used primary human subchondral osteoblasts from normal and OA individuals. Cells were stimulated, or not, with 100 ng/ml IGF-1 for up to 5 min. Proteins were separated by SDS-PAGE or immunoprecipitated with anti-insulin receptor substrate-1 (anti-IRS-1) antibodies followed by SDS-PAGE, and detected with selective antibodies.

Results

Upon binding to its receptor (IGF-1R), IGF-1 activates the p42/44 mitogen-activated protein kinase (MAPK) pathway using SHC or phosphorylation of IRS-1 via Grb2. The interaction of IRS-1 with IGF-1R is also modulated via the binding of a tyrosine phosphatase, Syp. IGF-1R α-subunits, SHC, IRS-1, Syp, Grb2 and p42/44 MAPK levels, by Western blot analysis, were similar in normal and OA osteoblasts under basal condition and following IGF-1 treatment. IGF-1 stimulated IGF-1R autophosphorylation in normal and OA osteoblasts similarly. However, IRS-1 phosphorylation was reduced whereas p42/44 MAPK phosphorylation was higher in OA osteoblasts than normal osteoblasts in response to IGF-1. In normal osteoblasts, Syp was poorly phosphorylated under basal conditions and rapidly became phosphorylated upon IGF-1 stimulation, while Syp was already highly phosphorylated under basal conditions in OA osteoblasts and was dephosphorylated upon IGF-1 stimulation. Co-immunoprecipitation of Syp using IRS-1 antibodies showed that this interaction is poor under basal conditions in normal cells yet increases following IGF-1 treatment, while in OA osteoblasts this interaction was very strong and rapidly dropped with IGF-1 treatments, indicating that phospho-Syp is the trigger. Co-immunoprecipitation of Grb2 using IRS-1 antibodies showed that Grb2 interaction with IRS-1 was increased in OA osteoblasts compared with normal osteoblasts under basal conditions and following IGF-1 stimulation.

Conclusion

These results suggest that an abnormal interaction of phospho-Syp with IRS-1 in OA osteoblasts leads to a reduced activity of IRS-1-dependent pathways. In addition, the increased interaction of Grb2 with IRS-1 suggests that the SHC7–Grb2 interaction is reduced in OA osteoblasts, and hence could not explain the stimulation of p42/44 MAPK.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lajeunesse, D., Massicotte, F., Aubry, I. et al. Altered phosphorylation of Syp may be responsible for abnormal insulin-like growth factor-1 signaling in human osteoarthritic osteoblasts. Arthritis Res Ther 5, 63 (2003) doi:10.1186/ar864

Download citation

Keywords

  • Normal Osteoblast
  • Altered Phosphorylation
  • MAPK Level
  • Osteoblast Metabolism
  • Subchondral Osteoblast